simvastatin has been researched along with Nasopharyngeal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sun, FR; Sun, LM; Wang, M; Wang, SL | 1 |
Bosq, J; Busson, P; Faigle, W; Hirashima, M; Keryer, C; Loew, D; Middeldorp, J; Nishi, N; Pioche-Durieu, C; Souquère, S | 1 |
2 other study(ies) available for simvastatin and Nasopharyngeal Neoplasms
Article | Year |
---|---|
Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; NF-kappa B; Signal Transduction; Simvastatin | 2020 |
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
Topics: Blotting, Western; Carcinoma; Cell Line; Cell Transformation, Viral; Cytotoxins; Drug Resistance; Galectins; Herpesvirus 4, Human; Humans; Immunoprecipitation; Intracellular Membranes; Mass Spectrometry; Microscopy, Electron; Nasopharyngeal Neoplasms; Protein Binding; Simvastatin; Tumor Cells, Cultured; Viral Matrix Proteins | 2005 |